Sade Group

Cannabis-based Pharmaceutical Products

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in December 2015, Sade Group operates with 1–10 employees. The company gained significant attention in May 2019 when Ori Yehudai, following the $7.1 billion sale of Frutarom, joined as active chairman and investor.

Business overview

Sade Group develops cannabis-based pharmaceutical products, focusing on optimizing clinical outcomes through its ASAYA platform. This platform manages medical cannabis treatments using big data analysis and algorithms based on expert best practices. ASAYA integrates real-world patient data with machine learning, IoT, mobile applications, and predictive analytics to provide guidance for medical cannabis use. The company serves the medical cannabis ecosystem, including healthcare professionals, patients, growers, and researchers, operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis.

Strategic signal

In May 2019, Ori Yehudai, a prominent figure in the industry after the $7.1 billion sale of Frutarom, joined. This move signaled strong validation for Sade Group's strategic direction and potential within the medical cannabis sector, attracting investor attention to the company's future growth prospects.

Log in to access full profile

Company Intelligence Q&A

What is Sade Group's primary focus?
Sade Group focuses on developing cannabis-based pharmaceutical products and optimizing medical cannabis treatment outcomes through its ASAYA platform.
What technology does the ASAYA platform utilize?
The ASAYA platform integrates machine learning, IoT, mobile applications, and predictive analytics to provide practical guidance for medical cannabis care.
When was Sade Group founded?
Sade Group was founded in December 2015.
Who joined Sade Group as active chairman and investor in May 2019?
In May 2019, Ori Yehudai joined.
What was the outcome of Ori Yehudai's involvement with Sade Group?
In July 2019, Ori Yehudai departed from Sade Group after approximately two months in his role.
Log in to access full profile